Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol · 2023 · PMC10049954 · PMID 36399178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, patients who received 3 initial monthly IVT-AFL injections followed by regular treatment showed a trend of improved functional outcomes over 24 months (Online Resource 3 ) and 48 months (Fig. 2 ) compared with patients who received irregular treatment without the initial injections.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.